Blood Journal/X
Jun 7, 2025, 10:28
IL-10 From Tumoral B Cells Modulates the Diffuse Large B-Cell Lymphoma Microenvironment and Response to Immunotherapy
The Blood Journal featured a post highlighting the published article on X:
“Hallmarks of IL-10 deficiency predict R-CHOP response but reflect poor antitumor immunity in preclinical models and patients with DLBCL.”
Title: IL-10 from tumoral B cells modulates the diffuse large B-cell lymphoma microenvironment and response to immunotherapy
Authors: Marcos Garcia-Lacarte, Sara C. Grijalba, Javier Melchor, Marién Pascual, Enrique Goñi, Iñigo Clemente-Larramendi, Sandra Morales-Sánchez, María A. Burrell, Oscar Blanco, Adrián Arnaiz-Leché, Blanca S. Berrozpe, Maria Amann, Christian Klein, Pablo Umaña, Miguel Canales, José Ángel Martínez-Climent, Juan J. Lasarte, Pablo Sarobe, Francisco J. Novo, Sergio Roa
Find more posts on Hemostasis Today.
-
Jan 10, 2026, 15:02Dr Manikanta Receives AHA Fellowship to Investigate Platelet-Dependent Nucleic Acid-Sensing Pathways
-
Jan 10, 2026, 14:40Last day at ASH25 from Riten Kumar
-
Jan 10, 2026, 08:56Shivanand Kumatagi Reflects on His Visit to Rela Hospital
-
Jan 10, 2026, 08:48Mitchell Elkind: Why Is The American Heart Association Holding a Brain Health Symposium?
-
Jan 10, 2026, 08:41Fiona Robinson Invites You to NBDF Webinar on Research Grants
-
Jan 10, 2026, 08:30Melissa Korn Takes Front Page Award for Her WSJ Piece on Experiencing a Pulmonary Embolism
-
Jan 10, 2026, 08:20Aymar Akilimali on Malaria in the Democratic Republic of Congo
-
Jan 9, 2026, 12:17Louise St Germain Bannon Invites You to Self-Nominate for the ISTH Council
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome